T. Rowe Price Investment Management

T. Rowe Price Investment Management Portfolio holdings

AUM $158B
 

T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.

This Quarter Return
+10.06%
1 Year Return
+17.8%
3 Year Return
+76.83%
5 Year Return
10 Year Return
AUM
$158B
AUM Growth
+$158B
Cap. Flow
-$1.89B
Cap. Flow %
-1.2%
Top 10 Hldgs %
20.72%
Holding
751
New
94
Increased
317
Reduced
271
Closed
66

Sector Composition

1 Technology 29.18%
2 Healthcare 18.36%
3 Consumer Discretionary 13.25%
4 Industrials 10.53%
5 Financials 9.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SNA icon
651
Snap-on
SNA
$17B
$417K ﹤0.01% 1,338 +211 +19% +$65.8K
ACN icon
652
Accenture
ACN
$162B
$408K ﹤0.01% 1,364 +444 +48% +$133K
PAYX icon
653
Paychex
PAYX
$50.2B
$396K ﹤0.01% 2,717 +88 +3% +$12.8K
MIDD icon
654
Middleby
MIDD
$6.94B
$317K ﹤0.01% 2,198 -329 -13% -$47.4K
IOVA icon
655
Iovance Biotherapeutics
IOVA
$807M
$314K ﹤0.01% 182,436 -1,747,584 -91% -$3.01M
CVS icon
656
CVS Health
CVS
$92.8B
$178K ﹤0.01% +2,568 New +$178K
EW icon
657
Edwards Lifesciences
EW
$47.8B
$164K ﹤0.01% +2,090 New +$164K
TTC icon
658
Toro Company
TTC
$8B
$162K ﹤0.01% 2,282 -30,160 -93% -$2.14M
REGN icon
659
Regeneron Pharmaceuticals
REGN
$61.5B
$152K ﹤0.01% +288 New +$152K
BMY icon
660
Bristol-Myers Squibb
BMY
$96B
$145K ﹤0.01% +3,113 New +$145K
VRTX icon
661
Vertex Pharmaceuticals
VRTX
$100B
$133K ﹤0.01% +297 New +$133K
SNY icon
662
Sanofi
SNY
$121B
$83K ﹤0.01% +1,707 New +$83K
AZN icon
663
AstraZeneca
AZN
$248B
$64K ﹤0.01% +913 New +$64K
ICUI icon
664
ICU Medical
ICUI
$3.15B
$46K ﹤0.01% +343 New +$46K
TEVA icon
665
Teva Pharmaceuticals
TEVA
$21.1B
$39K ﹤0.01% +2,299 New +$39K
ENOV icon
666
Enovis
ENOV
$1.77B
$38K ﹤0.01% 1,202 -6,206,566 -100% -$196M
ONC
667
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$35K ﹤0.01% +143 New +$35K
PFE icon
668
Pfizer
PFE
$141B
$33K ﹤0.01% +1,354 New +$33K
MLTX icon
669
MoonLake Immunotherapeutics
MLTX
$3.54B
$25K ﹤0.01% +509 New +$25K
PODD icon
670
Insulet
PODD
$23.9B
$25K ﹤0.01% +79 New +$25K
ZLAB icon
671
Zai Lab
ZLAB
$3.68B
$25K ﹤0.01% +713 New +$25K
DXCM icon
672
DexCom
DXCM
$29.5B
$22K ﹤0.01% +243 New +$22K
APGE icon
673
Apogee Therapeutics
APGE
$2.17B
$21K ﹤0.01% +464 New +$21K
MRNA icon
674
Moderna
MRNA
$9.37B
$19K ﹤0.01% +681 New +$19K
ETNB icon
675
89bio
ETNB
$1.34B
$10K ﹤0.01% +974 New +$10K